{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:29:45Z","timestamp":1790958585110,"version":"4.1.0"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1097\/pas.0000000000000365","type":"journal-article","created":{"date-parts":[[2015,1,12]],"date-time":"2015-01-12T05:50:31Z","timestamp":1421041831000},"page":"294-303","source":"Crossref","is-referenced-by-count":93,"title":["Expression Profiles of MYC Protein and MYC Gene Rearrangement in Lymphomas"],"prefix":"10.1097","volume":"39","author":[{"given":"Karen M.","family":"Chisholm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles D.","family":"Bangs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos E.","family":"Bacchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hernan Molina-","family":"Kirsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athena","family":"Cherry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasodha","family":"Natkunam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-2-20210131","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.semcancer.2006.07.014","article-title":". The c-Myc target gene network.","volume":"16","author":"Dang","year":"2006","journal-title":"Semin Cancer Biol"},{"key":"R2-2-20210131","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/nature03677","article-title":". c-Myc-regulated microRNAs modulate E2F1 expression.","volume":"435","author":"ODonnell","year":"2005","journal-title":"Nature"},{"key":"R4-2-20210131","doi-asserted-by":"crossref","first-page":"3884","DOI":"10.1182\/blood-2013-05-498329","article-title":"Understanding MYC-driven aggressive B-cell lymphomas: pathogenesis and classification.","volume":"122","author":"Ott","year":"2013","journal-title":"Blood"},{"key":"R5-2-20210131","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/nrc904","article-title":"c-MYC: more than just a matter of life and death.","volume":"2","author":"Pelengaris","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"R6-2-20210131","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.bcmd.2010.08.002","article-title":". The impact of MYC expression in lymphoma biology: beyond Burkitt lymphoma.","volume":"45","author":"Smith","year":"2010","journal-title":"Blood Cells Mol Dis"},{"key":"R7-2-20210131","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/S0140-6736(11)61177-X","article-title":". Burkitts lymphoma.","volume":"379","author":"Molyneux","year":"2012","journal-title":"Lancet"},{"key":"R8-2-20210131","doi-asserted-by":"crossref","first-page":"3460","DOI":"10.1200\/JCO.2011.41.4342","article-title":". Immunohistochemical double-hit score is a strong predictor of outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone.","volume":"30","author":"Green","year":"2012","journal-title":"J Clin Oncol"},{"key":"R9-2-20210131","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1182\/blood-2012-06-435842","article-title":". MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphoma.","volume":"121","author":"Horn","year":"2013","journal-title":"Blood"},{"key":"R10-2-20210131","doi-asserted-by":"crossref","first-page":"e33813","DOI":"10.1371\/journal.pone.0033813","article-title":". Immunohistochemical detection of MYC-driven diffuse large B-cell lymphomas.","volume":"7","author":"Kluk","year":"2012","journal-title":"PLoS One"},{"key":"R11-2-20210131","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.1182\/blood.V92.9.3152","article-title":". Clinical relevance of BCL2, BCL6, and MYC rearrangements in diffuse large B-cell lymphoma.","volume":"92","author":"Kramer","year":"1998","journal-title":"Blood"},{"key":"R12-2-20210131","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1182\/blood-2009-05-220095","article-title":". MYC gene rearrangements are associated with a poor prognosis in diffuse large B-cell lymphoma patients treated with R-CHOP chemotherapy.","volume":"114","author":"Savage","year":"2009","journal-title":"Blood"},{"key":"R13-2-20210131","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1056\/NEJM198904203201605","article-title":". bcl-2 and other genomic alterations in the prognosis of large-cell lymphoma.","volume":"320","author":"Yunis","year":"1989","journal-title":"N Engl J Med"},{"key":"R14-2-20210131","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/hon.991","article-title":". Clinical significance and prognosis of MYC translocation in diffuse large B-cell lymphoma.","volume":"29","author":"Zhang","year":"2011","journal-title":"Hematol Oncol"},{"key":"R15-2-20210131","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1182\/blood-2009-03-212191","article-title":". Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival.","volume":"114","author":"Johnson","year":"2009","journal-title":"Blood"},{"key":"R16-2-20210131","doi-asserted-by":"crossref","first-page":"3452","DOI":"10.1200\/JCO.2011.41.0985","article-title":". Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone.","volume":"30","author":"Johnson","year":"2012","journal-title":"J Clin Oncol"},{"key":"R17-2-20210131","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/modpathol.3800500","article-title":". Lymphoid neoplasms associated with concurrent t(14;18) and 8q24c-MYC translocation generally have a poor prognosis.","volume":"19","author":"Kanungo","year":"2006","journal-title":"Mod Pathol"},{"key":"R18-2-20210131","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.3324\/haematol.11305","article-title":". The clinical presentation and prognosis of diffuse large B-cell lymphoma with t(14;18) and 8q24c-MYC rearrangement.","volume":"92","author":"Le Gouill","year":"2007","journal-title":"Haematologica"},{"key":"R19-2-20210131","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/modpathol.2011.147","article-title":". B-cell lymphomas with MYC8q24 rearrangements and IGHBCL2t(14;18)(q32;q21): an aggressive disease with heterogeneous histology, germinal center B-cell immunophenotype and poor outcome.","volume":"25","author":"Li","year":"2012","journal-title":"Mod Pathol"},{"key":"R20-2-20210131","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.3324\/haematol.11263","article-title":"High-grade B-cell lymphomaleukemia associated with t(14;18) and 8q24MYC rearrangement: a neoplasm of germinal center immunophenotype with poor prognosis.","volume":"92","author":"Lin","year":"2007","journal-title":"Haematologica"},{"key":"R21-2-20210131","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/leu.2008.344","article-title":". Clinical features and prognosis of de novo diffuse large B-cell lymphoma with t(14;18) and 8q24c-MYC translocations.","volume":"23","author":"Niitsu","year":"2009","journal-title":"Leukemia"},{"key":"R22-2-20210131","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/PAS.0b013e3181cd3aeb","article-title":". B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma.","volume":"34","author":"Snuderl","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"R23-2-20210131","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1097\/PAS.0b013e3181db83af","article-title":"Altered subcellular localization of c-Myc protein identifies aggressive B-cell lymphomas harboring a c-MYC translocation.","volume":"34","author":"Ruzinova","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"R24-2-20210131","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1097\/PAS.0b013e318244e2ba","article-title":". High levels of nuclear MYC protein predict the presence of MYC rearrangement in diffuse large B-cell lymphoma.","volume":"36","author":"Green","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"R25-2-20210131","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/j.1365-2559.2011.03978.x","article-title":". Immunohistochemical detection of MYC protein correlates with MYC gene status in aggressive B cell lymphomas.","volume":"59","author":"Tapia","year":"2011","journal-title":"Histopathology"},{"key":"R26-2-20210131","doi-asserted-by":"crossref","first-page":"4021","DOI":"10.1182\/blood-2012-10-460063","article-title":". MYCBCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program.","volume":"121","author":"Hu","year":"2013","journal-title":"Blood"},{"key":"R27-2-20210131","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/bjh.12763","article-title":". MYC and BCL2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with rituximab.","volume":"165","author":"Perry","year":"2014","journal-title":"Br J Haematol"},{"key":"R28-2-20210131","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1097\/PAS.0000000000000147","article-title":". Clinical significance of MYC expression andor high-grade morphology in non-Burkitt, diffuse aggressive B-cell lymphomas: a SWOG S9704 correlative study.","volume":"38","author":"Cook","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"R29-2-20210131","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/PAT.0000000000000076","article-title":"Detection of MYC rearrangement in high grade B cell lymphomas: correlation of MYC immunohistochemistry and FISH analysis.","volume":"46","author":"Lynnhtun","year":"2014","journal-title":"Pathology"},{"key":"R30-2-20210131","doi-asserted-by":"crossref","first-page":"6757","DOI":"10.1007\/s13277-014-1907-z","article-title":". MYC protein expression is associated with poor prognosis in diffuse large B cell lymphoma patients treated with RCHOP chemotherapy.","volume":"35","author":"Zhou","year":"2014","journal-title":"Tumour Biol"},{"key":"R31-2-20210131","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/his.12207","article-title":". Immunohistochemical evaluation of MYC expression in mantle cell lymphoma.","volume":"63","author":"Oberley","year":"2013","journal-title":"Histopathology"},{"key":"R32-2-20210131","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1097\/PAS.0000000000000213","article-title":". MYC protein expression is detected in plasma cell myeloma but not in monoclonal gammopathy of undetermined significance (MGUS).","volume":"38","author":"Xiao","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"R33-2-20210131","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1038\/leu.2011.53","article-title":". Clinical and biological implications of MYC activation: a common difference between MGUS and newly diagnosed multiple myeloma.","volume":"25","author":"Chng","year":"2011","journal-title":"Leukemia"},{"key":"R34-2-20210131","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1097\/PAS.0b013e3181f3e29f","article-title":". IGMYC rearrangements are the main cytogenetic alteration in plasmablastic lymphomas.","volume":"34","author":"Valera","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"R35-2-20210131","doi-asserted-by":"crossref","first-page":"6650","DOI":"10.1182\/blood-2011-02-336842","article-title":". Posttranscriptional deregulation of MYC via PTEN constitutes a major alternative pathway of MYC activation in T-cell acute lymphoblastic leukemia.","volume":"117","author":"Bonnet","year":"2011","journal-title":"Blood"},{"key":"R36-2-20210131","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1101\/gad.1450406","article-title":". c-Myc is an important direct target of Notch1 in T-cell acute lymphoblastic leukemialymphoma.","volume":"20","author":"Weng","year":"2006","journal-title":"Genes Dev"},{"key":"R37-2-20210131","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1182\/blood-2009-05-221275","article-title":". Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NKT-cell lymphoma, nasal type.","volume":"115","author":"Huang","year":"2010","journal-title":"Blood"},{"key":"R38-2-20210131","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.prp.2014.02.004","article-title":". Both c-Myc and Ki-67 expression are predictive markers in patients with extranodal NKT-cell lymphoma, nasal type: a retrospective study in China.","volume":"210","author":"Huang","year":"2014","journal-title":"Pathol Res Pract"},{"key":"R39-2-20210131","doi-asserted-by":"crossref","first-page":"597","DOI":"10.3324\/haematol.2009.012864","article-title":". Increased MYC gene copy number correlates with increased mRNA levels in diffuse large B-cell lymphoma.","volume":"95","author":"Stasik","year":"2010","journal-title":"Haematologica"},{"key":"R40-2-20210131","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/ng0993-56","article-title":". Point mutations in the c-Myc transactivation domain are common in Burkitts lymphoma and mouse plasmacytomas.","volume":"5","author":"Bhatia","year":"1993","journal-title":"Nat Genet"},{"key":"R41-2-20210131","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1126\/science.3685977","article-title":". Mutations in the first exon are associated with altered transcription of c-myc in Burkitt lymphoma.","volume":"238","author":"Cesarman","year":"1987","journal-title":"Science"},{"key":"R42-2-20210131","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/35085588","article-title":". Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas.","volume":"412","author":"Pasqualucci","year":"2001","journal-title":"Nature"},{"key":"R43-2-20210131","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1038\/leu.2009.64","article-title":". The impact of NOTCH1, FBW7 and PTEN mutations on prognosis and downstream signaling in pediatric T-cell acute lymphoblastic leukemia: a report from the Childrens Oncology Group.","volume":"23","author":"Larson Gedman","year":"2009","journal-title":"Leukemia"},{"key":"R44-2-20210131","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1084\/jem.20070876","article-title":". FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to gamma-secretase inhibitors.","volume":"204","author":"ONeil","year":"2007","journal-title":"J Exp Med"},{"key":"R45-2-20210131","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1084\/jem.20070872","article-title":". The SCFFBW7 ubiquitin ligase complex as a tumor suppressor in T cell leukemia.","volume":"204","author":"Thompson","year":"2007","journal-title":"J Exp Med"},{"key":"R46-2-20210131","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/path.2410","article-title":". MYC translocation-negative classical Burkitt lymphoma cases: an alternative pathogenetic mechanism involving miRNA deregulation.","volume":"216","author":"Leucci","year":"2008","journal-title":"J Pathol"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000000365","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T13:49:30Z","timestamp":1717681770000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000478-201503000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000000365","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]}}}